Kentucky Retirement Systems Insurance Trust Fund Has $1.22 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Kentucky Retirement Systems Insurance Trust Fund cut its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 12.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,128 shares of the medical research company’s stock after selling 749 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in IQVIA were worth $1,215,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Covestor Ltd boosted its position in shares of IQVIA by 45.3% in the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock worth $39,000 after purchasing an additional 48 shares during the last quarter. Resurgent Financial Advisors LLC boosted its holdings in IQVIA by 499.6% during the first quarter. Resurgent Financial Advisors LLC now owns 1,559 shares of the medical research company’s stock worth $394,000 after buying an additional 1,299 shares during the last quarter. O Shaughnessy Asset Management LLC grew its position in shares of IQVIA by 25.3% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 7,501 shares of the medical research company’s stock worth $1,897,000 after buying an additional 1,513 shares during the period. UniSuper Management Pty Ltd increased its stake in shares of IQVIA by 253.0% in the 1st quarter. UniSuper Management Pty Ltd now owns 6,029 shares of the medical research company’s stock valued at $1,525,000 after acquiring an additional 4,321 shares during the last quarter. Finally, Lake Street Advisors Group LLC acquired a new stake in shares of IQVIA in the 1st quarter valued at approximately $339,000. Institutional investors own 89.62% of the company’s stock.

Insider Activity

In related news, insider Eric Sherbet sold 1,300 shares of IQVIA stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 6.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on IQV shares. BTIG Research decreased their price objective on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a report on Friday, November 1st. Royal Bank of Canada reissued an “outperform” rating and issued a $270.00 price target on shares of IQVIA in a report on Friday, November 1st. UBS Group raised their price objective on IQVIA from $295.00 to $300.00 and gave the stock a “buy” rating in a research note on Tuesday, July 23rd. StockNews.com cut shares of IQVIA from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. lowered their target price on IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, IQVIA presently has a consensus rating of “Moderate Buy” and an average price target of $259.13.

IQVIA Price Performance

NYSE:IQV opened at $192.68 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The firm has a fifty day simple moving average of $226.95 and a 200 day simple moving average of $228.24. IQVIA Holdings Inc. has a 1-year low of $189.63 and a 1-year high of $261.73. The stock has a market capitalization of $34.97 billion, a PE ratio of 25.29, a P/E/G ratio of 1.98 and a beta of 1.51.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.